Because of their ability to detect only one specific biomolecule, antibodies are often viewed as the best way to interact with biosensors.
A strategy to mass produce them is the Hybridoma technology (developed in 1975 by Milstein, and Köhler). Briefly, a plasma B cell is fused together with a cancer cell, in this way, the plasma B cell does not die and will keep on producing millions of specific antibodies. [1]
Antibodies work well with ELISA (Enzyme Linked Immuno Sorbent Assay) where the antibodies detect a specific antigen and they are linked next with a fluoro-enzyme(an enzyme capable of emitting light), a deep analysis on a microscope will yield the response, if everything goes well, the assay will be as bright as a field of fireflies.
Antibodies have been also used in cantilevers or membranes (MEMS) to detect by weight the presence of a given antigen. [2] The detection strategy in this case, can be optical, piezoelectric, or even by capacitance.
Cantilever with antibodies, based on the size and weight, the cantilever can deflect downside or even upside as seen on [3] (with SCFV instead of antibodies) |
[1] Human antibodies by design, Vaughan, T. J, Osbourn, J. K, Tempest, P. R, Nature biotechnology, 16, 535-539 (1998)
[2] Cantilever transducers as a platform for chemical and biological sensors, Lavrik. N. V, Sepaniak, M. J, Datskos P. G, Review of scientific instruments, 75, 2220-2253 (2004)
[3] A label-free immunosensors array using single-chain antibody fragments, Backmann N, Zahnd C, Huber F, Bietsch A, Plückthun A, Lang H. P, Güntherodt H. J, Hegner M, Gerber C, PNAS, 102, 14587-14592 (2005)
No comments:
Post a Comment